SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2.82 |
| Enterprise Value ($M) | 30.47 |
| Book Value ($M) | 5.40 |
| Book Value / Share | 5.07 |
| Price / Book | 0.52 |
| NCAV ($M) | -12.75 |
| NCAV / Share | -11.97 |
| Price / NCAV | -0.22 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.04 |
| Return on Assets (ROA) | -0.49 |
| Return on Equity (ROE) | -0.88 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.11 |
| Current Ratio | 0.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.40 |
| Assets | 19.55 |
| Liabilities | 14.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,500 | 53,690 | 8.38 | |
| 2,661 | 38,583 | 6.90 | |
| 1,028 | 18,589 | 5.53 | |
| 10,090 | 150,514 | 6.70 | |
| 5,932 | 59,997 | 9.89 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AIMD – Ainos, Inc. | AKAN – Akanda Corp. |
| AKBA – Akebia Therapeutics, Inc. | ALDX – Aldeyra Therapeutics, Inc. |
| ALGS – Aligos Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io